|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||4.4569 - 4.4850|
|52 Week Range||3.9300 - 6.0400|
|Beta (5Y Monthly)||0.94|
|PE Ratio (TTM)||193.50|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||3.50|
BOSTON, November 18, 2021--PureTech announces that its Founded Entity, Gelesis, received a $30 million fully paid pre-order for Plenity® from Ro.
BOSTON, November 16, 2021--PureTech announces publication of Phase 1 results for LYT-100 in the journal Clinical Pharmacology in Drug Development and provides timing updates
BOSTON, November 15, 2021--PureTech announces that members of the management team will participate in fireside chats at two upcoming investor conferences.